Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ERO1LB |
| Upstream (Parents) |
|---|
| (<<) MOSC2 → ERO1LB |
| (<<) ENPEP → ERO1LB |
| (<<) C1RL → ERO1LB |
| (<<) STEAP3 → ERO1LB |
| Downstream (Children) |
|---|
| ERO1LB → RGR (>>) |
| ERO1LB → GP9 (>>) |
| ERO1LB → MPP6 (>>) |
| ERO1LB → NLRP2 (>>) |
| ERO1LB → ZFY (>>) |
| ERO1LB → RGS12 (>>) |
| ERO1LB → CCDC70 (>>) |
| ERO1LB → P2RY11 (>>) |
| ERO1LB → MRE11A (>>) |
| ERO1LB → RASL10A (>>) |
| ERO1LB → LOC100289523///LOC392555 (>>) |
| ERO1LB → HCG9 (>>) |
| ERO1LB → ARC (>>) |
| ERO1LB → C22orf24 (>>) |
